HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >

Sort by: In order: Results/Page Authors/Record:
Export metadata:
Showing results 1 to 20 of 34
 next >
TypeAuthor(s)TitleOther TitlesCitationCitation(alt)Issue Date
articleHosoda, Shunichi; Suda, Goki; Sho, Takuya; Ogawa, Koji; Kimura, Megumi; Yang, Zijian; Yoshida, Sonoe; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Ito, Jun; Miyagishima, Takuto; Sakamoto, NaoyaLow baseline CXCL9 predicts early progressive disease in unresectable HCC with atezolizumab plus bevacizumab treatment-Liver Cancer-Jun-2023
articleUchinami, Yusuke; Katoh, Norio; Abo, Daisuke; Morita, Ryo; Taguchi, Hiroshi; Fujita, Yoshihiro; Kanehira, Takahiro; Suzuki, Ryusuke; Miyamoto, Naoki; Takao, Seishin; Matsuura, Taeko; Sho, Takuya; Ogawa, Koji; Orimo, Tatsuya; Kakisaka, Tatsuhiko; Kobashi, Keiji; Aoyama, HidefumiStudy of hepatic toxicity in small liver tumors after photon or proton therapy based on factors predicting the benefits of proton-The British Journal of Radiology-1-Apr-2023
articleYang, Zijian; Suda, Goki; Maehara, Osamu; Ohara, Masatsugu; Yoda, Tomoka; Sasaki, Takashi; Kohya, Risako; Yoshida, Sonoe; Hosoda, Shunichi; Tokuchi, Yoshimasa; Kitagataya, Takashi; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, NaoyaChanges in Serum Growth Factors during Resistance to Atezolizumab Plus Bevacizumab Treatment in Patients with Unresectable Hepatocellular Carcinoma-Cancers-Feb-2023
articleKawagishi, Naoki; Suda, Goki; Yamamoto, Yoshiya; Baba, Masaru; Furuya, Ken; Maehara, Osamu; Ohnishi, Shunsuke; Yoshida, Sonoe; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Tokuchi, Yoshimasa; Kitagataya, Takashi; Ohara, Masatsugu; Suzuki, Kazuharu; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Ogawa, Koji; Sakamoto, NaoyaSerum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C-Viruses-Basel-Jan-2023
articleKawagishi, Naoki; Suda, Goki; Sakamori, Ryotaro; Matsui, Takeshi; Onozawa, Masahiro; Yang, Zijian; Yoshida, Sonoe; Ohara, Masatsugu; Kimura, Megumi; Kubo, Akinori; Maehara, Osamu; Fu, Qingjie; Hosoda, Shunichi; Tokuchi, Yoshimasa; Suzuki, Kazuharu; Nakai, Masato; Sho, Takuya; Morikawa, Kenichi; Natsuizaka, Mitsuteru; Ogawa, Koji; Sakai, Hajime; Ohnishi, Shunsuke; Baba, Masaru; Takehara, Tetsuo; Sakamoto, NaoyaSerum IL-1 beta predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy-Scientific reports-7-Oct-2022
articleSho, Takuya; Suda, Goki; Yamamoto, Yoshiya; Furuya, Ken; Baba, Masaru; Ogawa, Koji; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yang, Zijian; Kimura, Megumi; Kitagataya, Takashi; Maehara, Osamu; Ohnishi, Shunsuke; Nakamura, Akihisa; Yamada, Ren; Ohara, Masatsugu; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Suzuki, Kazuharu; Izumi, Takaaki; Meguro, Takashi; Terashita, Katsumi; Takagi, Tomofumi; Ito, Jun; Kobayashi, Tomoe; Miyagishima, Takuto; Sakamoto, NaoyaEfficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150-Cancers-15-Aug-2022
articleTakimoto-Sato, Michiko; Miyauchi, Toshinari; Suzuki, Masaru; Ujiie, Hideyuki; Nomura, Toshifumi; Ikari, Tomoo; Nakamura, Tomohiko; Takahashi, Kei; Matsumoto-Sasaki, Machiko; Kimura, Hirokazu; Kimura, Hiroki; Matsui, Yuichiro; Kitagataya, Takashi; Yamada, Ren; Suzuki, Kazuharu; Nakamura, Akihisa; Nakai, Masato; Sho, Takuya; Ogawa, Koji; Sakamoto, Naoya; Yamaguchi, Naoko; Otsuka, Noriyuki; Tomaru, Utano; Konno, SatoshiCase Report : Hereditary Fibrosing Poikiloderma With Tendon Contractures, Myopathy, and Pulmonary Fibrosis (POIKTMP) Presenting With Liver Cirrhosis and Steroid-Responsive Interstitial Pneumonia-Frontiers in Genetics-May-2022
articleNakai, Masato; Yamamoto, Yoshiya; Baba, Masaru; Suda, Goki; Kubo, Akinori; Tokuchi, Yoshimasa; Kitagataya, Takashi; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Sho, Takuya; Morikawa, Kenichi; Ogawa, Koji; Furuya, Ken; Sakamoto, NaoyaPrediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication-Scientific reports-27-Jan-2022
articleSuzuki, Kazuharu; Suda, Goki; Yamamoto, Yoshiya; Abiko, Satoshi; Kinoshita, Kenji; Miyamoto, Shuichi; Sugiura, Ryo; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Kitagataya, Takashi; Shigesawa, Taku; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, NaoyaEffect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B-PLoS ONE-20-Jan-2022
articleYang, Zijian; Suda, Goki; Maehara, Osamu; Ohara, Masatsugu; Yoshida, Sonoe; Hosoda, Shunichi; Kimura, Megumi; Kubo, Akinori; Tokuchi, Yoshimasa; Fu, Qingjie; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, NaoyaChanges in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma-Cancers-4-Jan-2022
articleTokuchi, Yoshimasa; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Kitagataya, Takashi; Kubo, Akinori; Yoshida, Sonoe; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Ohara, Masatsugu; Yamada, Ren; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, NaoyaPossible correlation between increased serum free carnitine levels and increased skeletal muscle mass following HCV eradication by direct acting antivirals-Scientific reports-16-Aug-2021
article (author version)Uchinami, Yusuke; Katoh, Norio; Abo, Daisuke; Taguchi, Hiroshi; Yasuda, Koichi; Nishioka, Kentaro; Soyama, Takeshi; Morita, Ryo; Miyamoto, Naoki; Suzuki, Ryusuke; Sho, Takuya; Nakai, Masato; Ogawa, Koji; Kakisaka, Tatsuhiko; Orimo, Tatsuya; Kamiyama, Toshiya; Shimizu, Shinichi; Aoyama, HidefumiTreatment outcomes of stereotactic body radiation therapy using a real-time tumor-tracking radiotherapy system for hepatocellular carcinomas-Hepatology Research-3-Aug-2021
articleYoshida, Sonoe; Suda, Goki; Ohara, Masatsugu; Fu, Qingjie; Yang, Zijian; Hosoda, Shunichi; Kimura, Megumi; Akinori, Kubo; Tokuchi, Yoshimasa; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Maehara, Osamu; Ohnishi, Shunsuke; Sakamoto, NaoyaFrequency and Characteristics of Overestimated Renal Function in Japanese Patients with Chronic Liver Disease and Its Relation to Sarcopenia-Nutrients-Jul-2021
articleKubo, Akinori; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kitagataya, Takashi; Ohara, Masatsugu; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Sakamoto, NaoyaCharacteristics and Lenvatinib Treatment Response of Unresectable Hepatocellular Carcinoma with Iso-High Intensity in the Hepatobiliary Phase of EOB-MRI-Cancers-Jul-2021
articleKawagishi, Naoki; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Tokuchi, Yoshimasa; Kubo, Akinori; Kitagataya, Takashi; Shigesawa, Taku; Suzuki, Kazuharu; Ohara, Masatsugu; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Sakamoto, NaoyaBaseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C-Scientific reports-28-Apr-2021
articleShigesawa, Taku; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Tokuchi, Yoshimasa; Kubo, Akinori; Yamada, Ren; Furuya, Ken; Baba, Masaru; Kitagataya, Takashi; Suzuki, Kazuharu; Ohara, Masatsugu; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, NaoyaBaseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma-PLoS ONE-1-Mar-2021
article (author version)Kitagataya, Takashi; Suda, Goki; Nagashima, Kazunori; Katsurada, Takehiko; Yamamoto, Koji; Kimura, Megumi; Maehara, Osamu; Yamada, Ren; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Ohnishi, Shunsuke; Komatsu, Yoshito; Hata, Hiroo; Takeuchi, Satoshi; Abe, Takashige; Sakakibara-Konishi, Jun; Teshima, Takanori; Homma, Akihiro; Sakamoto, NaoyaPrevalence, clinical course, and predictive factors of immune checkpoint inhibitor monotherapy-associated hepatitis in Japan-Journal of gastroenterology and hepatology-Oct-2020
articleShigesawa, Taku; Suda, Goki; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Yamada, Ren; Kitagataya, Takashi; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Sakamoto, NaoyaBaseline angiopoietin-2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma-JGH open-Oct-2020
article (author version)Kawagishi, Naoki; Suda, Goki; Kimura, Megumi; Maehara, Osamu; Shimazaki, Tomoe; Yamada, Ren; Kitagataya, Takashi; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Nakai, Masato; Sho, Takuya; Natsuizaka, Mitsuteru; Morikawa, Kenichi; Ogawa, Koji; Kudo, Yusuke; Nishida, Mutsumi; Sakamoto, NaoyaHigh serum angiopoietin-2 level predicts non-regression of liver stiffness measurement-based liver fibrosis stage after direct-acting antiviral therapy for hepatitis C-Hepatology Research-Jun-2020
articleSho, Takuya; Suda, Goki; Ogawa, Koji; Kimura, Megumi; Shimazaki, Tomoe; Maehara, Osamu; Shigesawa, Taku; Suzuki, Kazuharu; Nakamura, Akihisa; Ohara, Masatsugu; Umemura, Machiko; Kawagishi, Naoki; Natsuizaka, Mitsuteru; Nakai, Masato; Morikawa, Kenichi; Furuya, Ken; Baba, Masaru; Yamamoto, Yoshiya; Kobayashi, Tomoe; Meguro, Takashi; Saga, Akiyoshi; Miyagishima, Takuto; Yokoo, Hideki; Kamiyama, Toshiya; Taketomi, Akinobu; Sakamoto, NaoyaEarly response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting-JGH open-Feb-2020
Showing results 1 to 20 of 34
 next >

 

Hokkaido University